Kalle Känd

Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland.

Acino AG engages in the development and manufacture of pharmaceutical products. It also offers services such as registration, procurement, contract manufacturing, packaging, and logistics. Its products include solid oral dosage forms, patches, as well as biodegradable and subcutaneous implants. The company was founded by Wilfried Fischer in 1997 and is headquartered in Miesbach, Germany.

Acino Supply AG engages in the development, manufacture, purchase, and distribution of pharmaceutical products. It also coordinates all related activities. The company was founded on January 23, 2006 and is headquartered in Aesch, Switzerland.

Munir Sukhtian Pharmaceuticals engages in the manufacturing and distribution of pharmaceuticals. It undertakes marketing and branding of products for infections, obstetrics, gynecology and urinary tract disorders, and cardiovascular and musculoskeletal diseases. The company was founded in 1989 and is headquartered in Amman, Jordan.